Investigating the role of IRF3 in liver diseases caused by alcohol abuse
Transcriptional and non-transcriptional function of IRF3 in ALD
This study is looking at how long-term drinking can harm the liver and cause diseases like hepatitis and fibrosis, and it’s trying to find new ways to help people heal by understanding how a specific protein and immune cells work together during liver damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10998989 on NIH RePORTER |
What this research studies
This research focuses on understanding how chronic alcohol abuse leads to various liver diseases, particularly alcohol-associated hepatitis and fibrosis. It explores the role of a protein called IRF3 in the immune response and its impact on liver injury and healing. By studying how immune cells interact with liver cells during alcohol-related damage, the research aims to identify new therapeutic strategies to improve patient outcomes. The approach includes using animal models to uncover the mechanisms behind liver disease progression and potential treatment targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from alcohol-associated liver disease, particularly those with advanced fibrosis or acute hepatitis.
Not a fit: Patients with liver diseases not related to alcohol consumption or those with early-stage liver conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively treat or prevent severe liver damage in patients with alcohol-related liver diseases.
How similar studies have performed: Previous research has shown promising results in understanding immune responses in liver diseases, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Nagy, Laura E. — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Nagy, Laura E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.